Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NRAC (C14orf180), also known as Nutritionally-regulated adipose and cardiac enriched protein homolog, is a predicted transmembrane protein mainly expressed in adipose tissue and heart. Expression is nutritionally regulated, decreasing during fasting and obesity, and is highly induced during adipocyte differentiation. Knockdown studies (in stem cell models) suggest a role in adipocyte lipid accumulation, implicating NRAC in metabolic regulation and possibly disease, although its precise molecular function remains poorly understood. There are no documented clinical drugs or validated biomarkers associated with NRAC, but its restricted tissue pattern and potential involvement in metabolism make it an emerging candidate for further research in metabolic and cardiovascular disorders.
Not established. No drugs targeting NRAC have a described mechanism; the physiological role relates to membrane localization and metabolic regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nutritionally-regulated adipose and cardiac enriched protein homolog (NRAC).